 | • レポートコード：QYR9N7085 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、うつ病薬のグローバル市場について調査・分析したレポートで、種類別（SSRI、SNRI、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・うつ病薬の世界市場規模 ・主要企業別市場シェア ・うつ病薬の世界市場規模：種類別（SSRI、SNRI、その他） ・うつ病薬の世界市場規模：用途別（病院、診療所、その他） ・うつ病薬のアメリカ市場規模（種類別、用途別） ・うつ病薬のヨーロッパ市場規模（種類別、用途別） ・うつ病薬の中国市場規模（種類別、用途別） ・うつ病薬の日本市場規模（種類別、用途別） ・うつ病薬の東南アジア市場規模（種類別、用途別） ・うつ病薬のインド市場規模（種類別、用途別） ・うつ病薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・うつ病薬の世界市場予測（2019年-2025年） ・うつ病薬の地域別市場予測（2019年-2025年） ... |
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.The classification of Depression Drugs includes SSRIs, SNRIs and others, and the proportion of SSRIs in 2016 is about 47%, and the proportion of SNRIs in 2016 is about 34%.Depression Drugs is widely used in hospitals, clinics and other places. The most proportion of Depression Drugs is hospitals, and the proportion in 2016 is 679%. The trend of hospitals is increasing.
Market competition is not intense. Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, Allergan, GSK, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2018, the global Depression Drugs market size was 15000 million US$ and it is expected to reach 18300 million US$ by the end of 2025, with a CAGR of 2.9% during 2019-2025.
This report focuses on the global Depression Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Depression Drugs development in United States, Europe and China.
The key players covered in this study
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
Market segment by Type, the product can be split into
SSRIs
SNRIs
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Depression Drugs status, future forecast, growth opportunity, key market and key players.
To present the Depression Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Depression Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Depression Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 SSRIs
1.4.3 SNRIs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Depression Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Depression Drugs Market Size
2.2 Depression Drugs Growth Trends by Regions
2.2.1 Depression Drugs Market Size by Regions (2014-2025)
2.2.2 Depression Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Depression Drugs Market Size by Manufacturers
3.1.1 Global Depression Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Depression Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Depression Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Depression Drugs Key Players Head office and Area Served
3.3 Key Players Depression Drugs Product/Solution/Service
3.4 Date of Enter into Depression Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Depression Drugs Market Size by Type (2014-2019)
4.2 Global Depression Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Depression Drugs Market Size (2014-2019)
5.2 Depression Drugs Key Players in United States
5.3 United States Depression Drugs Market Size by Type
5.4 United States Depression Drugs Market Size by Application
6 Europe
6.1 Europe Depression Drugs Market Size (2014-2019)
6.2 Depression Drugs Key Players in Europe
6.3 Europe Depression Drugs Market Size by Type
6.4 Europe Depression Drugs Market Size by Application
7 China
7.1 China Depression Drugs Market Size (2014-2019)
7.2 Depression Drugs Key Players in China
7.3 China Depression Drugs Market Size by Type
7.4 China Depression Drugs Market Size by Application
8 Japan
8.1 Japan Depression Drugs Market Size (2014-2019)
8.2 Depression Drugs Key Players in Japan
8.3 Japan Depression Drugs Market Size by Type
8.4 Japan Depression Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Depression Drugs Market Size (2014-2019)
9.2 Depression Drugs Key Players in Southeast Asia
9.3 Southeast Asia Depression Drugs Market Size by Type
9.4 Southeast Asia Depression Drugs Market Size by Application
10 India
10.1 India Depression Drugs Market Size (2014-2019)
10.2 Depression Drugs Key Players in India
10.3 India Depression Drugs Market Size by Type
10.4 India Depression Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Depression Drugs Market Size (2014-2019)
11.2 Depression Drugs Key Players in Central & South America
11.3 Central & South America Depression Drugs Market Size by Type
11.4 Central & South America Depression Drugs Market Size by Application
12 International Players Profiles
12.1 Intellipharmaceutics
12.1.1 Intellipharmaceutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Depression Drugs Introduction
12.1.4 Intellipharmaceutics Revenue in Depression Drugs Business (2014-2019)
12.1.5 Intellipharmaceutics Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Depression Drugs Introduction
12.2.4 Pfizer Revenue in Depression Drugs Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Depression Drugs Introduction
12.3.4 Eli Lilly Revenue in Depression Drugs Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Company Details
12.4.2 Company Description and Business Overview
12.4.3 Depression Drugs Introduction
12.4.4 Astrazeneca Revenue in Depression Drugs Business (2014-2019)
12.4.5 Astrazeneca Recent Development
12.5 Lundbeck
12.5.1 Lundbeck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Depression Drugs Introduction
12.5.4 Lundbeck Revenue in Depression Drugs Business (2014-2019)
12.5.5 Lundbeck Recent Development
12.6 Allergan
12.6.1 Allergan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Depression Drugs Introduction
12.6.4 Allergan Revenue in Depression Drugs Business (2014-2019)
12.6.5 Allergan Recent Development
12.7 GSK
12.7.1 GSK Company Details
12.7.2 Company Description and Business Overview
12.7.3 Depression Drugs Introduction
12.7.4 GSK Revenue in Depression Drugs Business (2014-2019)
12.7.5 GSK Recent Development
12.8 Otsuka Pharmaceutical
12.8.1 Otsuka Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Depression Drugs Introduction
12.8.4 Otsuka Pharmaceutical Revenue in Depression Drugs Business (2014-2019)
12.8.5 Otsuka Pharmaceutical Recent Development
12.9 Takeda
12.9.1 Takeda Company Details
12.9.2 Company Description and Business Overview
12.9.3 Depression Drugs Introduction
12.9.4 Takeda Revenue in Depression Drugs Business (2014-2019)
12.9.5 Takeda Recent Development
12.10 NHU Group
12.10.1 NHU Group Company Details
12.10.2 Company Description and Business Overview
12.10.3 Depression Drugs Introduction
12.10.4 NHU Group Revenue in Depression Drugs Business (2014-2019)
12.10.5 NHU Group Recent Development
12.11 Shionogi
12.12 APOTEX
12.13 Kanghong Pharma
12.14 HUAHAI
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Depression Drugs Key Market Segments
Table Key Players Depression Drugs Covered
Table Global Depression Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Depression Drugs Market Size Market Share by Type 2014-2025
Figure SSRIs Figures
Table Key Players of SSRIs
Figure SNRIs Figures
Table Key Players of SNRIs
Figure Others Figures
Table Key Players of Others
Table Global Depression Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Depression Drugs Report Years Considered
Table Global Depression Drugs Market Size 2014-2025 (Million US$)
Figure Global Depression Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Depression Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Depression Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Depression Drugs Market Share by Regions 2014-2019
Figure Global Depression Drugs Market Share by Regions 2014-2019
Figure Global Depression Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Depression Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Depression Drugs Market Share by Manufacturers (2014-2019)
Figure Global Depression Drugs Market Share by Manufacturers in 2018
Table Global Depression Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Depression Drugs Product/Solution/Service
Table Date of Enter into Depression Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Depression Drugs Market Size Share by Type (2014-2019)
Figure Global Depression Drugs Market Size Market Share by Type (2014-2019)
Table Global Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Depression Drugs Market Size Share by Application (2014-2019)
Figure Global Depression Drugs Market Size Market Share by Application (2014-2019)
Figure Global Depression Drugs Revenue Market Share by Application in 2018
Figure United States Depression Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Depression Drugs Market Share (2018-2019)
Table United States Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Depression Drugs Market Share by Type (2014-2019)
Table United States Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Depression Drugs Market Share by Application (2014-2019)
Figure Europe Depression Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Depression Drugs Market Share (2018-2019)
Table Europe Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Depression Drugs Market Share by Type (2014-2019)
Table Europe Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Depression Drugs Market Share by Application (2014-2019)
Figure China Depression Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Depression Drugs Market Share (2018-2019)
Table China Depression Drugs Market Size by Type (2014-20189) (Million US$)
Table China Depression Drugs Market Share by Type (2014-2019)
Table China Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table China Depression Drugs Market Share by Application (2014-2019)
Figure Japan Depression Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Depression Drugs Market Share (2018-2019)
Table Japan Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Depression Drugs Market Share by Type (2014-2019)
Table Japan Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Depression Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Depression Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Depression Drugs Market Share (2018-2019)
Table Southeast Asia Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Depression Drugs Market Share by Type (2014-2019)
Table Southeast Asia Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Depression Drugs Market Share by Application (2014-2019)
Figure India Depression Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Depression Drugs Market Share (2018-2019)
Table India Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table India Depression Drugs Market Share by Type (2014-2019)
Table India Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table India Depression Drugs Market Share by Application (2014-2019)
Figure Central & South America Depression Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Depression Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Depression Drugs Market Share (2018-2019)
Table Central & South America Depression Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Depression Drugs Market Share by Type (2014-2019)
Table Central & South America Depression Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Depression Drugs Market Share by Application (2014-2019)
Table Intellipharmaceutics Company Details
Table Intellipharmaceutics Revenue in Depression Drugs Business (2014-2019) (Million US$)
Figure Intellipharmaceutics Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Intellipharmaceutics Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Astrazeneca Recent Development
Table Lundbeck Company Details
Table Lundbeck Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Lundbeck Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Lundbeck Recent Development
Table Allergan Company Details
Table Allergan Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Allergan Recent Development
Table GSK Company Details
Table GSK Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table GSK Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Otsuka Pharmaceutical Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Otsuka Pharmaceutical Recent Development
Table Takeda Company Details
Table Takeda Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table Takeda Recent Development
Table NHU Group Company Details
Table NHU Group Revenue in Depression Drugs Business (2014-2019)(Million US$)
Figure NHU Group Revenue Growth Rate in Depression Drugs Business (2014-2019)
Table NHU Group Recent Development
Table Shionogi Company Details
Table APOTEX Company Details
Table Kanghong Pharma Company Details
Table HUAHAI Company Details
Table Global Depression Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Depression Drugs Market Size Share by Regions (2019-2025)
Figure Global Depression Drugs Market Size Share by Regions in 2025
Figure United States Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Depression Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Depression Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Depression Drugs Market Size by Product (2019-2025)
Figure Global Depression Drugs Market Size by Product in 2025
Table Global Depression Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Depression Drugs Market Size by Application (2019-2025)
Figure Global Depression Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…- 世界の産後うつ病治療薬市場：市場規模・現状・予測 Postpartum depression is a prevalent disorder affecting many women of reproductive age.Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depres…
- 世界の産後うつ病治療市場2019 The global Postpartum Depression Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Postpartum Depression Treatment market status and forecast, categorizes the global Postpartum Depre…
- 世界のテネクテプラーゼ薬市場：市場規模・現状・予測 Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug.It is estimated that North America dominated the …
- 世界の凍結乾燥注射薬市場：市場規模・現状・予測 Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period.In 2018, the global Lyophilized Injectable Drugs market size was xx million US$ and it is expected to reach xx million US$ by the …